DiaSorin Ltd

DiaSorin Ltd. are the prime provider in terms of complementary solution supply within the pathology managed service arena. Offering the most comprehensive immunoassay portfolio, DiaSorin currently has 72 LIAISON®XL placements in the UK and Ireland.

The Liaison®XL offers a multidisciplinary portfolio of over 110 assays including numerous unique, esoteric assays. The LIAISON® QuantiFERON®-TB Gold Plus assay is the most recent addition to the portfolio. Also having recently identified an unmet need for total automation within stool testing, we now facilitate stool testing on the LIAISON®XL platform alongside serology testing thus consolidating and improving the efficiency of the laboratory while streamlining the patient diagnostic pathway